Scarica l'app Stockscreener
33.28
1.89%
-0.64
Dopo l'orario di chiusura:
33.27
-0.010
-0.03%
First Tracks Biotherapeutics Inc Borsa (TRAX) Ultime notizie
CCORF Initiates First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Announces Target Price $50 - Moomoo
First Tracks Biotherapeutics (NASDAQ:TRAX) Stock Rated "Buy" in New Coverage at Canaccord Genuity Group - MarketBeat
Canaccord initiates First Tracks Biotherapeutics stock with buy By Investing.com - Investing.com South Africa
Canaccord initiates First Tracks Biotherapeutics stock with buy - Investing.com
First Tracks Biotherapeutics Inc Cash Flow – GETTEX:B43 - TradingView
First Tracks Biotherapeutics, Inc. (TRAX) Stock Price, News, Quote & History - Yahoo! Finance Canada
First Tracks Biotherapeutics Inc Balance Sheet – MUN:B43 - TradingView
First Tracks Biotherapeutics Inc Cash Flow – MUN:B43 - TradingView
Debt to assets ratio of First Tracks Biotherapeutics Inc – GETTEX:A428R1 - TradingView
First Tracks Biotherapeutics Inc Cash Flow – GETTEX:A428R1 - TradingView
State Street Corp Buys 1,512,896 Shares of First Tracks Biotherapeutics $TRAX - MarketBeat
AnaptysBio : Annual Transition Report (Form 10-KT) - marketscreener.com
Spin-off leaves AnaptysBio (ANAB) a lean royalty firm - Stock Titan
Anaptys Announces Second Quarter and Transitional Fiscal - GlobeNewswire
Why Did CRCL Stock Lose Steam? Wall Street Split On Circle’s Banking Win - Stocktwits
First Tracks Biotherapeutics Inc (TRAX) Stock Price, Quote, News & History - Benzinga
This Cue Biopharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
Evercore Initiates First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Announces Target Price $65 - Moomoo
John Orwin (TRAX) lifts direct stake to 17,995 shares - Stock Titan
First Tracks Biotherapeutics (NASDAQ:TRAX) Stock Rating Upgraded by Guggenheim - marketbeat.com
First Tracks Biotherapeutics stock rises on Guggenheim buy rating By Investing.com - Investing.com India
Why is First Tracks Biotherapeutics stock rallying today? By Investing.com - Investing.com Canada
First Tracks Biotherapeutics stock rises on Guggenheim buy rating - Investing.com
Guggenheim initiates coverage of First Tracks with Buy rating, $100 price target - TradingView
Guggenheim initiates First Tracks stock with buy on autoimmune drug potential - Investing.com Canada
First Tracks Biotherapeutics Inc Actuals & Estimates (NASDAQ:TRAX) - TradingView
Basic earnings per share (basic EPS) of First Tracks Biotherapeutics Inc – FWB:B43 - TradingView
First Tracks Biotherapeutics Inc Cash Flow – FWB:B43 - TradingView
ETFs Investing in First Tracks Biotherapeutics Inc Stocks - TradingView
First Tracks Biotherapeutics at wells fargo healthcare conference: data loom By Investing.com - Investing.com South Africa
First Tracks Biotherapeutics Insider Ware J. Anthony Sells 39,265 Shares at $44.78 Following Option Exercise - Kalkine Media
TRAX Price Today: First Tracks Biotherapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC
First Tracks Biotherapeutics Director Sold Shares Worth Over $1.7M - TradingView
First Tracks Biotherapeutics (TRAX) director sells shares after option exercise - Stock Titan
H.C. Wainwright Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $57 - Moomoo
TRAX Reiterates by First Tracks -- Price Target Maintained at $5 - GuruFocus
Long term debt to total assets ratio of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Which stocks are gapping on Wednesday? - ChartMill
Dell, Gitlab surge 11-14% on strong Q2 results; Sirius XM rises - scanx.trade
Cash flow from operating activities of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
EBIT per share of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Revenue per share of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Tangible book value per share of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Return on assets % of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Price to book ratio of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - tradingview.com
Total debt of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
After tax other income/expense of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
First Tracks Biotherapeutics Announces Participation in September Investor Conferences - Yahoo Finance
Non-controlling/minority interest of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Total liabilities of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Taxes of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Diluted shares outstanding of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Total operating expenses of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Diluted earnings per share (diluted EPS) of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - tradingview.com
First Tracks Biotherapeutics, Inc. Revenue Breakdown – NASDAQ:TRAX - TradingView
Total revenue of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - tradingview.com
Dilution adjustment of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Price to cash flow ratio of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
CapEx per share of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Number of shareholders of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Enterprise value to EBITDA forward of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - tradingview.com
Net debt of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Gross profit of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
EBIT of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Net current asset value per share of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Free cash flow of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Total liabilities & shareholders' equities of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Non-operating income (total) of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
Enterprise value to EBITDA ratio of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
EBITDA per share of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
0.05%
0.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):